Geode Capital Management, LLC Cabaletta Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 773,090 shares of CABA stock, worth $5.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

773,090

Previous 753,176 2.64%

Holding current value

$5.71 Million

Previous $17.1 Million 22.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$16.79 - $25.38 $334,356 - $505,417	19,914 Added 2.64%	773,090 $13.2 Million
Q4 2023 Feb 13, 2024	BUY	$12.21 - $23.36 $748,521 - $1.43 Million	61,304 Added 8.86%	753,176 $17.1 Million
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $2.24 Million - $3.53 Million	189,145 Added 37.62%	691,872 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$7.65 - $13.95 $2.16 Million - $3.95 Million	282,877 Added 128.67%	502,727 $6.49 Million
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $80,818 - $144,057	-11,415 Reduced 4.94%	219,850 $1.82 Million

Q4 2022 Feb 13, 2023	BUY	$1.76 - $9.3 $179,141 - $946,600	101,785 Added 78.61%	231,265 $2.14 Million
Q2 2022 Aug 12, 2022	BUY	$0.99 - $2.11 $6,806 - $14,506	6,875 Added 5.61%	129,480 $137,000
Q1 2022 May 13, 2022	SELL	$1.68 - $3.92 $1 - $3	-1 Reduced -0.0%	122,605 $248,000
Q4 2021 Feb 11, 2022	BUY	$3.36 - $14.64 $13,325 - $58,062	3,966 Added 3.34%	122,606 $464,000
Q3 2021 Nov 12, 2021	BUY	$7.0 - $12.5 $6,846 - $12,225	978 Added 0.83%	118,640 $1.44 Million
Q2 2021 Aug 13, 2021	SELL	$7.2 - $11.73 $608,270 - $990,973	-84,482 Reduced 41.79%	117,662 $1.01 Million
Q1 2021 May 12, 2021	BUY	$10.39 - $14.53 $268,436 - $375,397	25,836 Added 14.65%	202,144 $2.24 Million
Q4 2020 Feb 12, 2021	BUY	$9.81 - $15.8 $96,657 - $155,677	9,853 Added 5.92%	176,308 $2.2 Million
Q3 2020 Nov 13, 2020	SELL	$9.71 - $14.41 $177,158 - $262,910	-18,245 Reduced 9.88%	166,455 $1.8 Million
Q2 2020 Aug 13, 2020	BUY	$6.39 - $11.28 $233,183 - $411,629	36,492 Added 24.62%	184,700 $2.06 Million
Q1 2020 May 14, 2020	BUY	$6.0 - $18.67 $224,604 - $698,892	37,434 Added 33.79%	148,208 $1.08 Million
Q4 2019 Feb 13, 2020	BUY	$7.88 - $17.71 $872,899 - $1.96 Million	110,774 New	110,774 $1.55 Million

Others Institutions Holding CABA

# of Institutions

168

Shares Held

48.8M

Call Options Held

300K

Put Options Held

1.31M

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $214M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cabaletta Bio, Inc. Transaction History